• 1. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 2. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
• 3. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 4. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 5. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833

Professional Introduction to 2,6-Dichlorophenol-Indo-O-Cresol Sodium Salt (CAS No. 5415-26-9)

2,6-Dichlorophenol-Indo-O-Cresol Sodium Salt, with the chemical identifier CAS No. 5415-26-9, is a specialized compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound, characterized by its unique structural properties, has been explored for its potential applications in various biochemical pathways and therapeutic interventions. The sodium salt form of this compound enhances its solubility and stability, making it a valuable candidate for further investigation in drug development.

The molecular structure of 2,6-Dichlorophenol-Indo-O-Cresol Sodium Salt consists of a phenolic group linked to an indole moiety, with chloro substituents at the 2 and 6 positions of the phenol ring. This arrangement confers specific electronic and steric properties that are crucial for its interaction with biological targets. The presence of the sodium salt form further modulates these properties, facilitating better integration into aqueous environments and enhancing its pharmacokinetic profile.

In recent years, there has been a growing interest in exploring the pharmacological potential of 2,6-Dichlorophenol-Indo-O-Cresol Sodium Salt. Research has indicated that this compound exhibits promising activities against various pathological conditions. For instance, studies have suggested that it may possess anti-inflammatory and antioxidant properties, which are critical in managing chronic diseases such as arthritis and neurodegenerative disorders. The compound's ability to modulate inflammatory pathways is attributed to its interaction with key enzymes and transcription factors involved in the inflammatory response.

Moreover, the indole moiety in the structure of 2,6-Dichlorophenol-Indo-O-Cresol Sodium Salt has been identified as a crucial element for its biological activity. Indole derivatives are well-documented for their diverse pharmacological effects, including antimicrobial, antiviral, and anticancer properties. The chloro substituents at the 2 and 6 positions of the phenol ring enhance the compound's lipophilicity, which is essential for crossing biological membranes and reaching intracellular targets. This dual functionality makes 2,6-Dichlorophenol-Indo-O-Cresol Sodium Salt a versatile molecule with broad therapeutic implications.

The sodium salt form of this compound has also been investigated for its potential role in drug delivery systems. The enhanced solubility provided by the sodium counterion allows for more efficient formulation into oral or injectable medications. This characteristic is particularly advantageous in clinical settings where bioavailability and patient compliance are critical factors. Researchers have explored various delivery mechanisms, including nanotechnology-based approaches, to optimize the therapeutic efficacy of 2,6-Dichlorophenol-Indo-O-Cresol Sodium Salt.

In clinical trials and preclinical studies, 2,6-Dichlorophenol-Indo-O-Cresol Sodium Salt has demonstrated encouraging results in models of inflammation and oxidative stress. These findings have prompted further investigation into its potential as a lead compound for novel therapeutic agents. The compound's mechanism of action involves multiple pathways, including inhibition of cyclooxygenase (COX) enzymes and modulation of nuclear factor kappa B (NF-κB) signaling. These interactions contribute to its anti-inflammatory effects by reducing pro-inflammatory cytokine production.

The structural diversity of 2,6-Dichlorophenol-Indo-O-Cresol Sodium Salt also makes it a valuable scaffold for structure-activity relationship (SAR) studies. By modifying specific functional groups within the molecule, researchers can fine-tune its pharmacological properties to improve efficacy and reduce side effects. This approach has led to the identification of several derivatives with enhanced therapeutic profiles. For example, modifications at the indole ring have resulted in compounds with improved binding affinity to target proteins.

The synthesis of 2,6-Dichlorophenol-Indo-O-Cresol Sodium Salt involves multi-step organic reactions that require precise control over reaction conditions to ensure high yield and purity. Advanced synthetic methodologies have been employed to optimize these processes, including catalytic hydrogenation and palladium-catalyzed cross-coupling reactions. These techniques enhance the efficiency of production while minimizing environmental impact.

The safety profile of 2,6-Dichlorophenol-Indo-O-Cresol Sodium Salt is another critical aspect that has been thoroughly evaluated in preclinical studies. Toxicological assessments have revealed that the compound exhibits low toxicity at therapeutic doses, with minimal side effects observed in animal models. However, further studies are needed to fully characterize its safety profile in human populations.

The future directions for research on 2,6-Dichlorophenol-Indo-O-Cresol Sodium Salt include exploring its potential in combination therapies with other drugs to enhance treatment outcomes. Additionally, investigating its role in personalized medicine approaches could provide tailored therapeutic strategies based on individual patient profiles. The compound's multifaceted biological activities make it a promising candidate for addressing complex diseases that require multifaceted treatment regimens.

In conclusion, 2,6-Dichlorophenol-Indo-O-Cresol Sodium Salt (CAS No. 5415-26-9) is a highly intriguing compound with significant potential in pharmaceutical applications. Its unique structural features and demonstrated biological activities position it as a valuable asset in drug development efforts aimed at treating inflammatory diseases and other pathological conditions. As research continues to uncover new insights into its mechanisms of action and therapeutic benefits, this compound is poised to play a crucial role in advancing medical treatments.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)